NIAID Resource Opportunity: RFA-2024-001

This opportunity supports research focused on developing novel diagnostic tools and therapeutics for emerging infectious diseases. Funding is available for collaborative projects involving advanced molecular techniques and clinical validation.

Eligibility and Scope

The funding is open to academic institutions, non-profit research organizations, and industry partners. Proposals must demonstrate a clear pathway from basic research to translational application.

Key Requirements

• Project Duration: Minimum of 3 years.
• Focus Areas: Viral pathogenesis, diagnostic assay development, and vaccine platform technologies.
• Deliverables: Pre-clinical data packages and a comprehensive dissemination plan.

Application Details

Interested parties should review the full Request for Applications (RFA) document for detailed guidelines. The deadline for submission is October 30, 2024.

Note: This listing is based on preliminary information. Please consult the official funding portal for the most current guidelines.